Cargando…
E2F1-Dependent Oncogenic Addiction of Melanoma Cells to MDM2
One of the defining features of aggressive melanomas is their complexity. Hundreds of mutations and an ever increasing list of changes in the transcriptome and proteome distinguish normal from malignant melanocytic cells. Yet, despite this altered genetic background, a long-known attribute of melano...
Autores principales: | Verhaegen, Monique, Checinska, Agnieszka, Riblett, Mary Beth, Wang, Shaomeng, Soengas, María S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193861/ https://www.ncbi.nlm.nih.gov/pubmed/21743494 http://dx.doi.org/10.1038/onc.2011.277 |
Ejemplares similares
-
MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-A
por: Alatawi, Abdullah, et al.
Publicado: (2021) -
Small-Molecule Inhibitors
of the MDM2–p53 Protein–Protein
Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment: Miniperspective
por: Zhao, Yujun, et al.
Publicado: (2014) -
MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma
por: Forschner, Andrea, et al.
Publicado: (2020) -
Context-Dependent Requirement for dE2F during Oncogenic Proliferation
por: Nicolay, Brandon N., et al.
Publicado: (2008) -
MDM2 Oncogene Copy Number Alterations in Chronic Lymphocytic Leukemia
por: Sookaromdee, Pathum, et al.
Publicado: (2019)